Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
159
datasets available to search
ShareScore release 0.9.0
Dataset results
159 results for “Convalescent Plasma”
Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study
ClinicalTrials.gov study NCT04384497. IPD Sharing: YES. Countries: 1. Publications: 0.
Use of Multiple Doses of Convalescent Plasma in Mechanically Intubated Patients With COVID-19
ClinicalTrials.gov study NCT05595538. IPD Sharing: NO. Countries: 1. Publications: 0.
Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19
ClinicalTrials.gov study NCT04452812. IPD Sharing: YES. Countries: 1. Publications: 0.
Effectiveness of Convalescent Immune Plasma Therapy
ClinicalTrials.gov study NCT04442958. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO)
ClinicalTrials.gov study NCT04712344. IPD Sharing: NO. Countries: 1. Publications: 0.
"NORPLASMA" Covid-19 Convalescent Plasma Treatment Monitoring Study
ClinicalTrials.gov study NCT04463823. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Human Coronavirus-immune Convalescent Plasma for the Treatment of COVID-19 Disease in Hospitalized Children
ClinicalTrials.gov study NCT04377568. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Covid-19 Convalescent Plasma as Prevention and Treatment for Children With Underlying Medical Conditions
ClinicalTrials.gov study NCT04462848. IPD Sharing: NO. Countries: 1. Publications: 0.
Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications
ClinicalTrials.gov study NCT04374487. IPD Sharing: NO. Countries: 1. Publications: 0.
Convalescent Plasma for Treating Patients With COVID-19 Pneumonia Without Indication of Ventilatory Support
ClinicalTrials.gov study NCT04528368. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt
ClinicalTrials.gov study NCT04816942. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)
ClinicalTrials.gov study NCT04360486. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Convalescent Plasma for the Treatment of Patients With COVID-19
ClinicalTrials.gov study NCT04372368. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Convalescent Plasma to Limit Coronavirus Associated Complications
ClinicalTrials.gov study NCT04325672. IPD Sharing: NO. Countries: 0. Publications: 0.
Experimental Expanded Access Treatment With Convalescent Plasma for the Treatment of Patients With COVID-19
ClinicalTrials.gov study NCT04445207. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Testing Convalescent Plasma vs Best Supportive Care
ClinicalTrials.gov study NCT04333251. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Randomized, Double Blinded, Placebo-Controlled Clinical Trial Evaluating the Efficacy and Safety of anti-SARS-CoV-2 Convalescent Plasma in Hospitalized Patients (CONTAIN COVID-19)
<p>This dataset contains de-identified patient data of 941 patients from 21 centers across the United States who were enrolled in the CONTAIN COVID-19 randomized controlled trial that ran from 4/17/2020-3/15/2021. The information in this dataset was used to conduct the analysis reported in the CONTAIN COVID-19 manuscript published in JAMA Internal Medicine (doi: 10.1001/jamainternmed.2021.6850) and includes demographic information, baseline history, baseline medications, baseline laboratory values, clinical status based on the WHO 11-point scale at 14 and 28 days after randomization, antibody titers, randomization arms.</p>
Convalescent Plasma in Hospitalized COVID-19 Patients
ClinicalTrials.gov study NCT05157165. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Arkansas Expanded Access COVID-19 Convalescent Plasma Treatment Program
ClinicalTrials.gov study NCT04363034. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.